MELDUNG VOM 19.05.2017 12:20
Meldung drucken Artikel weiterleiten
pta20170519027
Public disclosure of inside information according to article 17 MAR
Pressefach Pressefach

Biofrontera AG: Biofrontera enters into finance contract with European Investmentbank

Leverkusen (pta027/19.05.2017/12:20) - Biofrontera AG (FSE: B8F), the specialist for the treatment of sun-induced skin cancer, and the European Investment Bank (EIB) have entered into an agreement today according to which the EIB will provide a loan of up to EUR 20 Million to the Biofrontera-Group. The loan is secured by a guarantee of the European Fund for Strategic Investments (EFSI). Up to EUR 10 Million will be available for disbursement from signature. Further EUR 10 Million may be drawn in two tranches within the next 24 months based on prior achievement of operational milestones. There is no obligation to call these tranches and no obligation to pay any commitment interest. Each tranche must be repaid five years after drawdown.

The Management Board

(Ende)

Aussender: Biofrontera AG
Hemmelrather Weg 201
51377 Leverkusen
Deutschland
Ansprechpartner: Investor & public relations
Tel.: +49 (0) 214 87 63 20
E-Mail:
Website: www.biofrontera.com
ISIN(s): DE0006046113 (share)
Börsen: regulated market in Dusseldorf, Frankfurt; free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate
Biofrontera AG
AKTUELLE BUSINESS NEWS
23.08.2017 13:15
Online-Banking in Deutschland immer populärer
pressetext.redaktion
23.08.2017 11:35
PH NÖ: Masterlehrgänge gestartet
Pädagogische Hochschule Niederösterreich
23.08.2017 11:00
Arvato präsentiert innovative Lösungen für ein ganzheitliches Kommunikations- und Shoppingerlebnis
Arvato infoscore GmbH - part of Arvato Financial Solutions
23.08.2017 10:10
Wirtschaftsspionage: Wenn rote Linien überschritten werden
Business Circle, Management Fortbildungs GmbH
Weitere News anzeigen